NDC 51662-1620-01 - NALOXONE HCl

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
51662-1620
Requested NDC
51662-1620-01
Package NDCs from labels
51662-1620-1, 51662-1620-2, 51662-1620-01
Manufacturer
HF Acquisition Co LLC, DBA HealthFirst
Effective date
2024-01-28
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
NALOXONE HCl - HF Acquisition Co LLC, DBA HealthFirstHF Acquisition Co LLC, DBA HealthFirst2024-01-28HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
51662-1620-1NALOXONE HCl0.1 mL in 1 VIAL, SINGLE-DOSESPRAY0.12
51662-1620-2NALOXONE HCl0.1 mL in 1 VIAL, SINGLE-DOSESPRAY0.12
51662-1620-2NALOXONE HCl2 in 1 CARTONSPRAY22

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
51662-1620NALOXONE HCL SPRAY [HF ACQUISITION CO LLC, DBA HEALTHFIRST]2Current NDC, 3 package rows20240130_f8fcda15-8ba6-e66a-e053-6294a90a385c.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 6 of 6 · 102 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Naloxone HydrochlorideNALOXONE HYDROCHLORIDEMylan Institutional LLCf0932877-1f3b-4d5e-82d2-dd6c53db47302020-08-17Warnings, Adverse reactionsExact identifier
unii: F850569PQR
Naloxone HydrochlorideNALXONE HYDROCHLORIDEHikma Pharmaceuticals USA Inc.8cc25cf1-008c-4808-baec-49f35a887fae2020-03-20Warnings, Adverse reactionsExact identifier
unii: F850569PQR

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.